Vivos Therapeuticsinc Stock EBITDA
| VVOS Stock | USD 2.64 0.08 2.94% |
Vivos TherapeuticsInc fundamentals help investors to digest information that contributes to Vivos TherapeuticsInc's financial success or failures. It also enables traders to predict the movement of Vivos Stock. The fundamental analysis module provides a way to measure Vivos TherapeuticsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vivos TherapeuticsInc stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -16.7 M | -17.5 M |
Vivos | EBITDA |
Vivos TherapeuticsInc Company EBITDA Analysis
Vivos TherapeuticsInc's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Vivos TherapeuticsInc EBITDA | (16.68 M) |
Most of Vivos TherapeuticsInc's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vivos TherapeuticsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vivos EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Vivos TherapeuticsInc is extremely important. It helps to project a fair market value of Vivos Stock properly, considering its historical fundamentals such as EBITDA. Since Vivos TherapeuticsInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vivos TherapeuticsInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vivos TherapeuticsInc's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Vivos Ebitda
Ebitda |
|
According to the company disclosure, Vivos TherapeuticsInc reported earnings before interest,tax, depreciation and amortization of (16.68 Million). This is 101.9% lower than that of the Health Care Equipment & Supplies sector and 102.6% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.43% higher than that of the company.
Vivos EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vivos TherapeuticsInc's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vivos TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Vivos TherapeuticsInc by comparing valuation metrics of similar companies.Vivos TherapeuticsInc is currently under evaluation in ebitda category among related companies.
Vivos TherapeuticsInc Institutional Holders
Institutional Holdings refers to the ownership stake in Vivos TherapeuticsInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vivos TherapeuticsInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vivos TherapeuticsInc's value.| Shares | Blackrock Inc | 2023-12-31 | 42.0 | Global Retirement Partners, Llc. | 2023-12-31 | 23.0 | Cutler Group Lp | 2023-12-31 | 12.0 | Steward Partners Investment Advisory, Llc | 2023-12-31 | 8.0 | Wells Fargo & Co | 2023-12-31 | 7.0 | Royal Bank Of Canada | 2023-12-31 | 7.0 | Apexium Financial, Lp | 2023-12-31 | 0.0 | Two Sigma Investments Llc | 2023-09-30 | 0.0 | Virtu Financial Llc | 2023-09-30 | 0.0 | Strategic Wealth Designers | 2023-12-31 | 128.8 K | Armistice Capital, Llc | 2023-12-31 | 57 K |
Vivos Fundamentals
| Return On Equity | -5.21 | ||||
| Return On Asset | -0.88 | ||||
| Profit Margin | (0.98) % | ||||
| Operating Margin | (1.27) % | ||||
| Current Valuation | 7.78 M | ||||
| Shares Outstanding | 2.98 M | ||||
| Shares Owned By Insiders | 7.30 % | ||||
| Shares Owned By Institutions | 13.73 % | ||||
| Number Of Shares Shorted | 18.69 K | ||||
| Price To Book | 18.94 X | ||||
| Price To Sales | 0.57 X | ||||
| Revenue | 13.8 M | ||||
| Gross Profit | 12.6 M | ||||
| EBITDA | (16.68 M) | ||||
| Net Income | (13.58 M) | ||||
| Cash And Equivalents | 17.83 M | ||||
| Cash Per Share | 0.77 X | ||||
| Total Debt | 2 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 3.15 X | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | (11.95 M) | ||||
| Short Ratio | 0.24 X | ||||
| Earnings Per Share | (11.14) X | ||||
| Target Price | 7.22 | ||||
| Number Of Employees | 114 | ||||
| Beta | 7.9 | ||||
| Market Capitalization | 8.11 M | ||||
| Total Asset | 10.73 M | ||||
| Retained Earnings | (93.05 M) | ||||
| Working Capital | (4.83 M) | ||||
| Net Asset | 10.73 M |
About Vivos TherapeuticsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vivos TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivos TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivos TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vivos TherapeuticsInc is a strong investment it is important to analyze Vivos TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vivos TherapeuticsInc's future performance. For an informed investment choice regarding Vivos Stock, refer to the following important reports:Check out Vivos TherapeuticsInc Piotroski F Score and Vivos TherapeuticsInc Altman Z Score analysis. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.